7-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 500mg

(3-Oxopiperazin-2-yl)acetic acid, 97.0%, 5g

(3S,4S)-tert-Butyl 3-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 5g

tert-Butyl 3-iodo-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate, 95.0%, 1g

Methyl 4-formyl-2-methoxybenzoate, 96%, 1g

(4-Methyl-1,3-thiazol-2-yl)methanol, 97.0%, 250mg

Bifenthrin>98.0%(GC)250mg

(R)-4-Cyclohexyl-2-(2-(diphenylphosphanyl)phenyl)-4,5-dihydrooxazole, 98+%, 100mg

(2-Amino-benzothiazol-6-yl)-acetic acid, 95.0%, 250mg

N-bromosuccinimide, min. 98%, for synthesis, 100 g, glass packaging

(R)-Methyl 3-hydroxytetradecanoate, 98%, 250mg

(R)-2-amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid, 98%, 250mg

(6-quinolinylmethyl)amine dihydrochloride, 95.0%, 5g